Evotec: Deep red figures - | Shares in free fall again:

deraktionaer.de/artikel/pharma-biotech/evotec-analyst-sieht-125-prozent-kurschance-die-details-20398004.html

Credibility C

Mar 26

Evotec: Analyst sees 125 percent share price potential - | The details: Evotec struggles financially, receives milestone payments and BARDA deal; Berenberg ...

deraktionaer.de/artikel/pharma-biotech/evotec-aktie-heftig-durchgeschuettelt-und-nun-20389876.html

Nov 06 25

Evotec: Shares shaken up – what now?: Evotec sells biotech subsidiary in Toulouse to Sandoz for $350 million, operating loss increases, revenue declines ...

deraktionaer.de/artikel/pharma-biotech/evotec-aktie-an-mdax-spitze-das-ist-der-grund-20384104.html

Jul 30 25

Evotec: Share at the top of the MDAX - | this is the reason: Evotec plans to sell biologics site to Sandoz for $300 million to promote capital-light model.

deraktionaer.de/artikel/pharma-biotech/evotec-aktie-bricht-massiv-ein-was-ist-da-los-20383542.html

Jul 21 25

Evotec: Share price collapses massively - | what's going on?: Evotec share price plummets after lowered sales forecast; EBITDA targets remain the same.

deraktionaer.de/artikel/pharma-biotech/evotec-mit-kurssprung-staerkster-wert-im-mdax-vor-traton-und-bilfinger-20380744.html

May 23 25

Evotec jumps share price - | strongest stock in the MDAX ahead of Traton and Bilfinger

deraktionaer.de/artikel/pharma-biotech/evotec-mit-zahlen-aktie-taucht-erneut-ab-20379514.html

May 06 25

Evotec with figures - | Share price plunges again: Evotec reports Q1 revenue decline, confirms annual targets and long-term outlook until 2028.

deraktionaer.de/artikel/pharma-biotech/evotec-gute-news-aktie-gibt-erneut-gas-20378875.html

Apr 24 25

Evotec: Good News - | Share Gains Again: Evotec shares rise following progress in the cooperation with Bristol Myers Squibb and a positive annual report.

abendblatt.de/hamburg/article408812292/hamburger-biotechkonzern-evotec-will-beteiligungen-verkaufen.html

Hamburger Abendblatt

B−

Apr 17 25

Hamburg biotech company Evotec wants to sell its holdings: The Hamburg biotech company has presented its 2024 annual report (archive image).

Jan 04 25

Buy shares: Insiders made a lot of money with these shares in 2024: Last year, executive and supervisory board members bought shares in their own companies for ...

handelsblatt.com/finanzen/maerkte/aktien/aktien-kaufen-mit-diesen-aktien-haben-insider-2024-viel-geld-verdient/100093909.html

boerse-online.de/nachrichten/aktien/wird-die-lage-bei-der-evotec-aktie-immer-schlimmer-anleger-haben-jetzt-1-alternative-20370889.html

0 0

BÖRSE ONLINE

Nov 29 24

Is the situation with Evotec shares getting worse? Investors now have one alternative

The San Diego Union-Tribune

sandiegouniontribune.com/2024/11/22/san-diegos-halozyme-withdraws-proposed-2-1b-acquisition-of-evotec/

Nov 23 24

San Diego’s Halozyme withdraws $2.1B Evotec bid, just one week after making offer

Key FactsEvotec's MDAX Comeback on the Horizon

Nov 22, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: deraktionaer.de

Evotec may be poised for a return to the MDAX by the end of the year, as JPMorgan predicts the company's inclusion in the mid-cap index.

Halozyme Therapeutics has made a takeover offer for Evotec at 11 euros per share, valuing the company at around two billion euros.

Despite the stock briefly rising to 10.69 euros, it is currently hovering around the 10-euro mark, while Evotec aims to resist the takeover attempt.

For a successful deal, higher bids will be necessary, and Evotec must regain investor confidence to ensure long-term success.

6 similar articles

Frankfurter Allgemeine Zeitung

faz.net/aktuell/wirtschaft/unternehmen/uebernahmeofferte-das-buhlen-um-evotec-beginnt-110114242.html

Nov 15 24

Takeover offer: The wooing of Evotec begins

Paid articlePaywall

Takeover offer: The wooing of Evotec begins: The Hamburg-based biotechnology company has now actually become a takeover candidate. A first concrete offer from a ...

7 similar articles

0 0

deraktionaer.de/artikel/pharma-biotech/evotec-extreme-ausschlaege-20370001.html

Nov 14 24

Evotec: Extreme Ausschläge: Evotec shares lose over 50% on an annual basis, but recover with 51.9% in a 1-month comparison as the SDAX leader.

Key FactsEvotec: Stock Shows Extreme Transformation

Nov 14, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: deraktionaer.de

Evotec's stock experienced a significant decline of over 50% last year but is now the top SDAX performer with a 51.9% monthly increase.

New CEO Christian Wojczewski announced progress on strategic initiatives aimed at long-term growth.

Speculation of a takeover arose as Triton acquired 9.16% of Evotec's voting rights, although the company denied any discussions.

Regaining investor confidence is crucial for Evotec, which needs to deliver important news in the coming months.

deraktionaer.de/artikel/aktien/evotec-vor-den-zahlen-die-spannung-steigt-geht-die-rally-weiter-20369405.html

Nov 05 24

Evotec before the figures: The tension is rising - | will the rally continue?: Evotec sells production facility, focuses on profitable growth and expects ...

deraktionaer.de/artikel/pharma-biotech/evotec-hochspannung-wichtiger-termin-voraus-20369311.html

Nov 01 24

Evotec: High tension - | important date ahead: Evotec shares rise; 9-month figures and outlook expected; expanded partnership with Bristol Myers Squibb and Novo ...

Frankfurter Allgemeine Zeitung

faz.net/aktuell/wirtschaft/unternehmen/neuer-evotec-chef-steht-vor-grossen-herausforderungen-19826707.html

Jul 04 24

Paid articlePaywall

New Evotec boss faces major challenges: Christian Wojczewski takes the helm of the Hamburg biotechnology company in turbulent times. He is an expert in upheavals ...

2 similar articles

0 0

deraktionaer.de/artikel/pharma-biotech/evotec-nach-dem-horror-crash-wars-das-20356124.html

Apr 25 24

Evotec after the horror crash - was that it?: Evotec shares fall below 10 euros; new CEO and cost-cutting plan fail to reassure investors.

6 similar articles

deraktionaer.de/artikel/technischeanalyse/evotec-aktie-uebel-zugerichtet-und-es-droht-schlimmeres-20349263.html

Feb 01 24

Evotec: Shares badly damaged and there is a threat of worse: Evotec shares suffer from leadership change and loss of trust, fall to multi-year low below 14 euros ...

Frankfurter Allgemeine Zeitung